Blocking T cells shielded mouse brains from Alzheimer's damage — without touching tau

Claim

IMMUNE CELLS WORSEN IT?

Catch

MICE ONLY

Verdict

A SHIELD, NOT A CURE

Current Alzheimer's medications (lecanemab, donanemab) target amyloid and slow decline, but no approved treatment stops brain cells from dying. A new study in Neuron (Emmerson et al., 2026, Washington University School of Medicine in St. Louis) tested a different idea: that part of the damage comes from the immune system's response to tau, not tau alone. In mice with tau buildup similar to Alzheimer's, immune T cells follow a chemical signal called CXCL10 (whose receptor, CXCR3, sits on the T cells) into the brain. Mice that lacked either CXCL10 or CXCR3 let no T cells in, even when researchers deliberately provoked inflammation. With an anti-CXCR3 antibody injected every five days for three and a half months, treated mice ended with about half as many T cells in their brains, kept roughly 40% more tissue in memory-related regions, showed less evidence of neuronal injury, and did better on a memory test — while the amount of tau in their brains stayed unchanged. The antibody also reached only the border of the brain, not the tissue inside, suggesting the immune response could be targeted from outside the blood-brain barrier. The catch: this is a mouse model only, animals were treated early before major brain cell loss, and safety and effectiveness in humans are unknown. The researchers suggest already-approved T-cell-directed drugs (like some multiple sclerosis treatments) as a possible starting point for future research — not a treatment today. If you or a loved one are affected by dementia, talk to a doctor about currently available care.

SOURCES

1. Emmerson, J. T., Hu, H., Savani, V., Lin, P., Rohde, M., Sharma, P., ... Ulrich, J. D., & Holtzman, D. M. (2026), "Peripheral CXCR3 blockade mitigates T cell infiltration and neurodegeneration in a mouse model of tauopathy," Neuron. DOI: 10.1016/j.neuron.2026.08.030 (PMID: 42805185)
2. Washington University School of Medicine in St. Louis, "Blocking immune cells' path into brain limits neurodegeneration" (October 20, 2026)

For information only, not medical advice. Alzheimer's and related dementias are serious conditions — please talk to a doctor or neurologist about diagnosis and treatment options.